Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)
Crossref DOI link: https://doi.org/10.1007/s00259-014-2788-5
Published Online: 2014-05-21
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kong, G.
Thompson, M.
Collins, M.
Herschtal, A.
Hofman, M. S.
Johnston, V.
Eu, P.
Michael, M.
Hicks, Rodney J.
License valid from 2014-05-21